BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 29347944)

  • 21. Intratumoral Heterogeneity of SMAD4 Immunohistochemical Expression and Its Role in Prediction of Recurrence Pattern in Patients with Resectable Pancreatic Cancer.
    Pokataev I; Kudaibergenova A; Artemyeva A; Popova A; Rumyantsev A; Podluzhny D; Kudashkin N; Fedyanin M; Tryakin A; Tjulandin S
    J Gastrointest Cancer; 2019 Sep; 50(3):478-484. PubMed ID: 29675723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Jagged1 and DLL4 expressions in benign and malignant pancreatic lesions and their clinicopathological significance.
    Huang SF; Yang ZL; Li DQ; Liu ZY; Wang CW; Miao XY; Zou Q; Yuan Y
    Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):640-646. PubMed ID: 27919854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of FOXM1 is associated with poor prognosis and clinicopathologic stage of pancreatic ductal adenocarcinoma.
    Xia JT; Wang H; Liang LJ; Peng BG; Wu ZF; Chen LZ; Xue L; Li Z; Li W
    Pancreas; 2012 May; 41(4):629-35. PubMed ID: 22249132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
    Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of UbcH10 in pancreatic ductal adenocarcinoma and its correlation with prognosis.
    Zhao ZK; Wu WG; Chen L; Dong P; Gu J; Mu JS; Yang JH; Liu YB
    Tumour Biol; 2013 Jun; 34(3):1473-7. PubMed ID: 23355337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low expression of junctional adhesion molecule A is associated with metastasis and poor survival in pancreatic cancer.
    Fong D; Spizzo G; Mitterer M; Seeber A; Steurer M; Gastl G; Brosch I; Moser P
    Ann Surg Oncol; 2012 Dec; 19(13):4330-6. PubMed ID: 22549289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombospondin-1 expression as a prognostic predictor of pancreatic ductal carcinoma.
    Tobita K; Kijima H; Dowaki S; Oida Y; Kashiwagi H; Ishii M; Sugio Y; Sekka T; Ohtani Y; Tanaka M; Inokuchi S; Makuuchi H
    Int J Oncol; 2002 Dec; 21(6):1189-95. PubMed ID: 12429967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic intraglandular metastasis predicts poorer outcome in postoperative patients with pancreatic ductal carcinoma.
    Oguro S; Shimada K; Ino Y; Esaki M; Nara S; Kishi Y; Kosuge T; Kanai Y; Hiraoka N
    Am J Surg Pathol; 2013 Jul; 37(7):1030-8. PubMed ID: 23648465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
    Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL
    World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of delta-like ligand 4 predicts poor prognosis after curative resection for pancreatic cancer.
    Chen HT; Cai QC; Zheng JM; Man XH; Jiang H; Song B; Jin G; Zhu W; Li ZS
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S464-74. PubMed ID: 21822553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
    Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
    Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma.
    Andea A; Sarkar F; Adsay VN
    Mod Pathol; 2003 Oct; 16(10):996-1006. PubMed ID: 14559982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low UGP2 Expression Is Associated with Tumour Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.
    Hu Q; Shen S; Li J; Liu L; Liu X; Zhang Y; Zhou Y; Zhu W; Yu Y; Cui G
    Dis Markers; 2020; 2020():3231273. PubMed ID: 32733617
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder.
    Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X
    World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions.
    Xiong L; Deng X; Wen Y; Yang Z; Miao X
    World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging.
    Basturk O; Saka B; Balci S; Postlewait LM; Knight J; Goodman M; Kooby D; Sarmiento JM; El-Rayes B; Choi H; Bagci P; Krasinskas A; Quigley B; Reid MD; Akkas G; Maithel SK; Adsay V
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1187-95. PubMed ID: 26362048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas.
    Jia N; Dong S; Zhao G; Gao H; Li X; Zhang H
    J Cancer Res Ther; 2016; 12(2):892-6. PubMed ID: 27461670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.